您的位置: 首页 > 农业专利 > 详情页

Benzimidazol was replaced as a modulator of tumor necrosis factor activity.
专利权人:
UCB Biopharma SPRL
发明人:
HEER, Jag Paul
申请号:
CL2019001511
公开号:
CL2019001511A1
申请日:
2019.06.04
申请国别(地区):
CL
年份:
2019
代理人:
摘要:
Lt. lt; P gt; 2 - (5 - {1 - [2 - (difluoromethane) - 6-fluorobenzene] - 2-methyl-1hbancimidazol-6-il} pirimidin-2-il) propane-2-OL, or a drug salt and amp; eacute; this is acceptable and a powerful regulator of TNF amp activity; ALPA; human, therefore beneficial to treatment and / or prevention and amp; various human diseases of lucf; Including autoimmunity and inflammation; neuropathy and amp disorders; oacute; gicos and neurodegeneration; pain and harmful disorders; cardiovascular disorders; Metab amp; oacute; LiCo; eye diseases; Oncol amp; oacute; gicos. lt; / P gt;<;p>;2-(5-{1-[2-(DIFLUOROMETOXI)-6-FLUOROBENCIL]-2-METIL-1HBENCIMIDAZOL-6-IL}PIRIMIDIN-2-IL)PROPAN-2-OL, O UNA SAL FARMACÉ;UTICAMENTE ACEPTABLE DEL MISMO, QUE SON POTENTES MODULADORES DE LA ACTIVIDAD DEL TNF&Alpha; HUMANO, SON POR LO TANTO BENEFICIOSOS EN EL TRATAMIENTO Y/O PREVENCIÓ;N DE DIVERSAS DOLENCIAS HUMANAS, INCLUYENDO TRASTORNOS AUTOINMUNES E INFLAMATORIOS; TRASTORNOS NEUROLÓ;GICOS Y NEURODEGENERATIVOS; DOLOR Y TRASTORNOS NOCICEPTIVOS; TRASTORNOS CARDIOVASCULARES; TRASTORNOS METABÓ;LICOS; TRASTORNOS OCULARES; Y TRASTORNOS ONCOLÓ;GICOS.<;/p>;
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充